Dr John Goodlad
- Honorary Clinical Senior Lecturer (School of Cancer Sciences)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Bouttell, J. , Fraser, H. , Goodlad, J. R., Hopkins, D. , McKay, P., Oien, K. A. , Seligmann, B., Von Delft, S. and Hawkins, N. (2024) Adding a gene expression profile test to aid differential diagnosis and treatment in aggressive large B-cell lymphoma: an early exploratory economic evaluation. Applied Health Economics and Health Policy, 22(2), pp. 243-254. (doi: 10.1007/s40258-023-00845-1) (PMID:38017318)
Bouttell, J. , Hawkins, N. , Masson, R. and Goodlad, J. (2023) OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation. HTAi 2023 Annual Meeting, Adelaide, Australia, 24-28 June 2023. S21–S21. (doi: 10.1017/s0266462323000995)
Goodlad, J. R., Cerroni, L. and Swerdlow, S. H. (2023) Recent advances in cutaneous lymphoma—implications for current and future classifications. Virchows Archiv, 482(1), pp. 281-298. (doi: 10.1007/s00428-022-03421-5) (PMID:36278991) (PMCID:PMC9852132)
Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)
Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)
Bouttell, J. , Fraser, H. , Goodlad, J. R., Hopkins, D. , McKay, P., Oien, K. A. , Seligmann, B., Von Delft, S. and Hawkins, N. (2024) Adding a gene expression profile test to aid differential diagnosis and treatment in aggressive large B-cell lymphoma: an early exploratory economic evaluation. Applied Health Economics and Health Policy, 22(2), pp. 243-254. (doi: 10.1007/s40258-023-00845-1) (PMID:38017318)
Goodlad, J. R., Cerroni, L. and Swerdlow, S. H. (2023) Recent advances in cutaneous lymphoma—implications for current and future classifications. Virchows Archiv, 482(1), pp. 281-298. (doi: 10.1007/s00428-022-03421-5) (PMID:36278991) (PMCID:PMC9852132)
Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)
Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)
Bouttell, J. , Hawkins, N. , Masson, R. and Goodlad, J. (2023) OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation. HTAi 2023 Annual Meeting, Adelaide, Australia, 24-28 June 2023. S21–S21. (doi: 10.1017/s0266462323000995)